Michael J. Tomsicek
Overview
Michael J. Tomsicek received an average of $3M in total compensation, including $337K in salary, at CRISPR Therapeutics AG from 2017 to 2021. Michael Tomsicek also received an average of $2M at ABIOMED from 2016 to 2018.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
CRISPR Therapeutics AGFormer Chief Financial Officer
CRISPR Therapeutics AGChief Financial Officer
CRISPR Therapeutics AGChief Financial Officer
ABIOMEDVice President, Chief Financial Officer and Treasurer
CRISPR Therapeutics AGChief Financial Officer
ABIOMEDVice President, Chief Financial Officer and Treasurer
CRISPR Therapeutics AGChief Financial Officer
ABIOMEDVice President, Chief Financial Officer and Treasurer
Source: SEC filings on April 25, 2022, April 28, 2021, April 24, 2020, June 22, 2018, April 30, 2019, and June 23, 2017.
Related executives
We found 17 more executives who work or worked at CRISPR Therapeutics AG and ABIOMED.
Michael Minogue
ABIOMED
Chief Executive Officer
Todd Trapp
ABIOMED
Chief Financial Officer
Andrew Greenfield
ABIOMED
Executive Vice President and Chief Commercial Officer
Marc Began
ABIOMED
General Counsel
David Weber
ABIOMED
Chief Operating Officer
Samarth Kulkarni
CRISPR Therapeutics AG
Chief Executive Officer
Brendan Smith
CRISPR Therapeutics AG
Chief Financial Officer
Tony Ho
CRISPR Therapeutics AG
Former EVP, Research and Development
News
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2021 pay jumps 87% to $17M
April 25, 2022
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2020 pay falls 44% to $9.1M
April 28, 2021
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2019 pay jumps 67% to $16M
April 24, 2020
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2018 pay jumps 40% to $9.7M
April 30, 2019
ABIOMED CEO Michael Minogue's 2018 pay slips 16% to $10M
June 22, 2018